Sanfilippo gene therapy got early support from affected families
Reported byNPR Health ↗·Sourced by Goodlede
The O'Neill family, whose daughter Eliza has Sanfilippo syndrome, raised millions of dollars for research that culminated in FDA approval of a gene therapy for the rare inherited disease, which causes children to lose speech and mobility and typically kills them in their teens.
Gene therapy for Sanfilippo is newly approved; long-term outcomes and broader effectiveness remain to be seen.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at NPR Health
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Environment
Suriname's Saamaka tribe turns to mapping and documenting in effort to protect the Amazon rainforest
ICT News · Verified
Science
Scientists discover dying coral can recover by touching healthy coral
CBC · Verified
Environment
Cranberry Bogs Were Unprofitable, Then Solar Saved The Day
CleanTechnica · Verified